Accelerate
the Longevity revolution

Kamen is an English barrister and a Bulgarian lawyer practising in the areas of disputes, corporate, regulatory and IP laws. He is a managing partner at New Balkans Law Office, a European firm which specialises in cross-border investments, technology and startup law.

With a background in biomedical science, Kamen has an interest in the design of policies encouraging the growth of the science and industry of longevity and is co-founding a think-tank in this field.

He has a BA in Law from Cambridge University.

‍

As a co-founder and managing partner at Tané, I invest and contribute to the crypto ecosystem, focusing on infrastructure and middleware such as L1, L2, MEV, and on-chain generative art.Tané is a crypto builders incubator based in NYC, Dubai, and Tokyo, with a vision of creating a better world where people can control their assets, data, and rights in a decentralized way through blockchain technology.

Hiro Hamada mainly works on cognitive and neural mechanisms of curiosity from behavioral and neural data. He also collaborates with other researchers with multiple interdisciplinary research on psychology, neuroscience, and philosophy.

Yoshiro Tasaka is the Director of the Global Strategy Division at the Shibuya City Government. With extensive experience in fostering relationships between major Japanese corporations, U.S. local governments, and various institutions, Yoshiro has organized numerous international events, including high-profile banquets and conferences. He is a recipient of the iOSDevCamp Hackathon’s Most Neighborly Award and holds a Master’s degree in International Relations and Affairs from San Francisco State University.

Mgoes is a Founding Steward at BiohackerDAO - a leading organization at the intersection of blockchain technology, citizen science, and radical human enhancement. Mgoes has been involved in web3 since 2014, previously serving as a core contributor, founder, or investor at several projects. He is a keen biohacker with a rate of aging of 0.74 and telomere length of a 12 year old.

Nathan Cheng is a pivotal figure in the longevity biotechnology sector. He is the General Partner at Healthspan Capital and Co-Founder of Vitalism. Nathan also serves as the Executive Director of the Longevity Biotech Fellowship. His career includes advisory roles at Less Death Inc and the creation of platforms like Longevity Marketcap and Longevity List. Nathan is a seasoned professional with a background in physics from the University of Toronto and has extensive experience in fostering innovation and investment in the longevity industry.

Peter Fedichev is a scientist and entrepreneur with over 20 years of experience in academic research and the biotech industry. As the CEO of Gero.ai, he leads the charge in using AI to combat aging and chronic diseases. With a strong foundation in physics and biology, Peter has held research positions at prestigious institutions like the University of Amsterdam and the Kurchatov Institute. His work has significantly contributed to our understanding of aging, aiming to extend human lifespan through innovative therapies.

Adam is a serial tech entrepreneur who has sold 4 companies, reaching over 80 million users. In most of his ventures, he was founding CEO, largely with a product and growth focus. He also has a neuroscience / software background and did some MRI-based research prior to startups. Since first hearing of Longevity Escape Velocity in 2005, Adam has been interested in longevity, and after the COVID pandemic, anguished by the unnecessary deaths and institutional incompetence, decided to focus on it as an investor and operator.To amplify progress by 2-3 orders of magnitude, he co-founded vitalism.io and supports various other efforts in the space.

Eriko Suzuki is a dedicated sustainability and wellbeing investor with extensive experience in venture capital. As the Founder and CEO of Kind Capital, she champions conscious and regenerative innovation. Eriko serves as a director for Tokyo Women in VC, a venture partner at Beyond Next Ventures, and holds multiple board positions. Her expertise spans finance, strategy, corporate governance, and holistic health, driving her commitment to fostering positive change through her investments and initiatives.

Bilal Kharouni is a seasoned entrepreneur based in Tokyo, Japan, currently serving as the Founder & CEO of ekei labs. With a strong foundation in technology and innovation, Bilal also holds a key position as a Board Member at La French Tech Tokyo, actively contributing to the advancement of the tech community. His entrepreneurial journey began with the establishment of ekei labs in July 2022, where he continues to drive growth and innovation. In addition to his roles in tech and entrepreneurship, Bilal is engaged as a Fellow at Longevity Biotech Fellowship, reflecting his broader interests in biotechnology and longevity sciences.

Erna Raja is an accomplished cell biologist currently serving as Assistant Professor at the University of Tsukuba since June 2022. With a robust academic background, Erna previously held positions as a Research Scientist at Kumamoto University for over three years and as a Project Researcher at The University of Tokyo for six years. She completed her PhD at Uppsala University after working as a lab technician at the National University of Singapore. Erna's research expertise spans multiple prestigious institutions, reflecting her dedication to advancing cellular biology.

Cat Thu Nguyen Huu is a freelance engineer deeply involved in longevity, crypto, and education. A graduate of Massachusetts Institute of Technology, Cat is currently core at VitaDAO, founder of "Longevity Zero to One," and supports the Longevity Prize. Cat also organizes longevity events through Zuzalu and serves as Chairwoman at UWC Vietnam. With expertise in software engineering, Cat is passionate about supporting biotech research and exploring computational biology.